MP060DETERMINING TREATMENT PREFERENCE FOR TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): DEVELOPMENT OF A DISCRETE CHOICE EXPERIMENT (DCE) FOR USE AS A CLINICAL STUDY ENDPOINT